How drug pages are confirmed before they go live

What we confirm

For guideline-based drug entries, we confirm the drug name, route category, section order, dose framing, contraindication details, and major precautions against the active source document before the page is treated as complete.

We keep the original section structure where possible so readers can move between the PDF guidance and the site version without losing context.

What we intentionally leave out

In the current drug workflow, the Storage and Remarks sections are intentionally excluded from the public page copy when a page is being converted from the guideline into the site format.

This keeps the public page focused on therapeutic action, indications, forms and strengths, dose guidance, duration, and safety precautions.

How batch confirmation works

We publish these drug pages in batches so content can be checked in manageable groups instead of attempting a full guideline conversion in one pass. That helps reduce skipped entries, ordering mistakes, and silent formatting failures.

The current rollout covers all 162 oral-drug entries, all 71 injectable-drug entries, all 6 infusion-fluid entries, all 20 vaccine and antiserum entries, all 31 external-use and antiseptic entries, and all 14 potentially dangerous, obsolete, or ineffective entries from the source guideline. Oral drugs are now complete here with 162 structured entries. Injectable drugs are now complete here with 71 structured entries. Infusion fluids are now complete here with 6 structured entries. Vaccines, immunoglobulins, and antisera are now complete here with 20 structured entries. Drugs for external use and antiseptics are now complete here with 31 structured entries. Potentially dangerous, obsolete, or ineffective entries are now complete here with 14 structured entries. This closes out the postable drug-information sections from the guideline.

Thin-content alerts

The admin dashboard includes an internal alert for drug pages with under 500 confirmed characters of copied medical content. Those entries are surfaced for manual review so short pages can be checked, expanded, or replaced when needed.

Reference pages

Some drug names in the source guideline are simple cross-references rather than full standalone monographs. When that happens, the site may publish a dedicated route that points readers to the main drug page instead of pretending there is separate full guidance.

Correction and review

If a page is mapped to the wrong source, misses a section, or needs fuller confirmation, the correct fix may be to revise the entry, replace it with a more complete version, or hold the next batch until the source alignment is clean.

This page exists to make that process visible rather than treating the publishing workflow as a black box.